Surmodics Statistics
Share Statistics
Surmodics has 14.29M shares outstanding. The number of shares has increased by 0.41% in one year.
| Shares Outstanding | 14.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.19% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 13.71M |
| Failed to Deliver (FTD) Shares | 2.49K |
| FTD / Avg. Volume | 1.15% |
Short Selling Information
The latest short interest is 336.64K, so 2.36% of the outstanding shares have been sold short.
| Short Interest | 336.64K |
| Short % of Shares Out | 2.36% |
| Short % of Float | 2.46% |
| Short Ratio (days to cover) | 1.87 |
Valuation Ratios
The PE ratio is -47.55 and the forward PE ratio is 137.54.
| PE Ratio | -47.55 |
| Forward PE | 137.54 |
| PS Ratio | 4.35 |
| Forward PS | 3.2 |
| PB Ratio | 4.62 |
| P/FCF Ratio | -169.19 |
| PEG Ratio | n/a |
Enterprise Valuation
Surmodics Inc. has an Enterprise Value (EV) of 438.24M.
| EV / Earnings | -37.97 |
| EV / Sales | 3.48 |
| EV / EBITDA | 368.89 |
| EV / EBIT | -77.63 |
| EV / FCF | -135.09 |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 3.96 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.28 |
| Total Debt / Capitalization | 21.85 |
| Cash Flow / Debt | 0.01 |
| Interest Coverage | -1.59 |
Financial Efficiency
Return on equity (ROE) is -0.1% and return on capital (ROIC) is -5.71%.
| Return on Equity (ROE) | -0.1% |
| Return on Assets (ROA) | -0.06% |
| Return on Capital (ROIC) | -5.71% |
| Revenue Per Employee | 335.31K |
| Profits Per Employee | -30.70K |
| Employee Count | 376 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.18 |
Taxes
| Income Tax | 4.04M |
| Effective Tax Rate | -0.54 |
Stock Price Statistics
The stock price has increased by 6.06% in the last 52 weeks. The beta is 1.2, so Surmodics 's price volatility has been higher than the market average.
| Beta | 1.2 |
| 52-Week Price Change | 6.06% |
| 50-Day Moving Average | 39.09 |
| 200-Day Moving Average | 37.82 |
| Relative Strength Index (RSI) | 14.55 |
| Average Volume (20 Days) | 217.46K |
Income Statement
In the last 12 months, Surmodics had revenue of 126.08M and earned -11.54M in profits. Earnings per share was -0.82.
| Revenue | 126.08M |
| Gross Profit | 93.05M |
| Operating Income | -5.64M |
| Net Income | -11.54M |
| EBITDA | 1.19M |
| EBIT | -5.64M |
| Earnings Per Share (EPS) | -0.82 |
Balance Sheet
The company has 36.12M in cash and 33.24M in debt, giving a net cash position of 2.87M.
| Cash & Cash Equivalents | 36.12M |
| Total Debt | 33.24M |
| Net Cash | 2.87M |
| Retained Earnings | 0 |
| Total Assets | 178.56M |
| Working Capital | 60.76M |
Cash Flow
In the last 12 months, operating cash flow was 248.00K and capital expenditures -3.49M, giving a free cash flow of -3.24M.
| Operating Cash Flow | 248.00K |
| Capital Expenditures | -3.49M |
| Free Cash Flow | -3.24M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 73.81%, with operating and profit margins of -4.48% and -9.15%.
| Gross Margin | 73.81% |
| Operating Margin | -4.48% |
| Pretax Margin | -5.95% |
| Profit Margin | -9.15% |
| EBITDA Margin | 0.94% |
| EBIT Margin | -4.48% |
| FCF Margin | -2.57% |
Dividends & Yields
SRDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.31% |
| FCF Yield | -0.64% |
Analyst Forecast
The average price target for SRDX is $43, which is 21% higher than the current price. The consensus rating is "Hold".
| Price Target | $43 |
| Price Target Difference | 21% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Dec 7, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 7, 2000 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 6.7 |
| Piotroski F-Score | 4 |